Search research articles
Contact Us
Filters
Showing results (251-260 of 329) with videos related to
Page
of 33
Sort By:
Comprehensive Psychiatry
|
March 21, 2016
An initial investigation of abnormal bodily phenomena in subjects at ultra high risk for psychosis: Their prevalence and clinical implications
Luis Madeira, Ilaria Bonoldi, Matteo Rocchetti, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms
Gemma Modinos, Fatma Simsek, Jamie Horder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 7, 2025
Antipsychotics cause reversible structural brain changes within one week
Pierluigi Selvaggi, Martin Osugo, Uzma Zahid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
Gemma Modinos, Anja Richter, Alice Egerton, et al.
Translational Psychiatry
|
July 20, 2021
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
June 8, 2021
The Effects of Acute Δ<sup>9</sup>-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study
Michael A P Bloomfield, Katherine Petrilli, Rachel Lees, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 9, 2020
The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study
Michael A P Bloomfield, Sebastian F Green, Chandni Hindocha, et al.
Schizophrenia Research
|
June 28, 2016
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Alice Egerton, Lucia R Valmaggia, Oliver D Howes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 25, 2020
Stress resilience during the coronavirus pandemic
Christiaan H Vinkers, Therese van Amelsvoort, Jonathan I Bisson, et al.
The Lancet. Psychiatry
|
January 12, 2023
Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study
Toby Pillinger, Emanuele F Osimo, Antonio de Marvao, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 329) with videos related to
Sort By:
Page
of 33
Comprehensive Psychiatry
|
March 21, 2016
An initial investigation of abnormal bodily phenomena in subjects at ultra high risk for psychosis: Their prevalence and clinical implications
Luis Madeira, Ilaria Bonoldi, Matteo Rocchetti, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms
Gemma Modinos, Fatma Simsek, Jamie Horder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 7, 2025
Antipsychotics cause reversible structural brain changes within one week
Pierluigi Selvaggi, Martin Osugo, Uzma Zahid, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
Gemma Modinos, Anja Richter, Alice Egerton, et al.
Translational Psychiatry
|
July 20, 2021
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
June 8, 2021
The Effects of Acute Δ<sup>9</sup>-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study
Michael A P Bloomfield, Katherine Petrilli, Rachel Lees, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 9, 2020
The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study
Michael A P Bloomfield, Sebastian F Green, Chandni Hindocha, et al.
Schizophrenia Research
|
June 28, 2016
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Alice Egerton, Lucia R Valmaggia, Oliver D Howes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 25, 2020
Stress resilience during the coronavirus pandemic
Christiaan H Vinkers, Therese van Amelsvoort, Jonathan I Bisson, et al.
The Lancet. Psychiatry
|
January 12, 2023
Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study
Toby Pillinger, Emanuele F Osimo, Antonio de Marvao, et al.
Page
of 33